Related Experiment Video

Updated: Aug 12, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all

V Kudryashov1, P W Glunz, L J Williams

  • 1Tumor Antigen Laboratory, Immunology Program and Bioorganic Chemistry Laboratory, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 15, 2001
PubMed

Insights

Synthetic carbohydrate vaccines show promise for cancer immunotherapy. Researchers optimized Lewis(y) (Le(y)) vaccine design in mice, achieving tumor-specific antibodies with clustered epitopes and specific adjuvants.

Area of Science:

  • Immunology
  • Carbohydrate Chemistry
  • Cancer Research

Background:

  • Carbohydrate-based vaccines are under investigation for cancer immunotherapy.
  • Lewis(y) (Le(y)) antigen is overexpressed on many human carcinomas, making it a target for cancer vaccines.
  • Optimal design of glycoconjugate vaccines, including epitope clustering, carrier structure, and adjuvants, requires further study.

Purpose of the Study:

  • To investigate the role of epitope clustering, carrier structure, and adjuvant in the immunogenicity of Lewis(y) (Le(y)) conjugates.
  • To evaluate the feasibility of an entirely synthetic carbohydrate-based anticancer vaccine.

Main Methods:

  • Developed and tested various Lewis(y) (Le(y)) glycopeptide constructs in mice.
  • Varied epitope density (single vs. clustered Le(y)-serine epitopes).
  • Examined different carrier proteins (keyhole limpet hemocyanin) and adjuvants (Pam(3)Cys, QS-21).

Main Results:

  • A glycolipopeptide with clustered Le(y)-serine epitopes and Pam(3)Cys elicited superior antitumor cell antibodies compared to a single epitope construct.
  • Coupling to keyhole limpet hemocyanin produced both IgM and IgG antibodies, but with limited reactivity.
  • A clustered Le(y)-serine Pam(3)Cys conjugate combined with QS-21 adjuvant induced both IgG and IgM antibodies that reacted with tumor cells.

Conclusions:

  • Epitope clustering and appropriate adjuvant selection are critical for enhancing the immunogenicity of carbohydrate-based cancer vaccines.
  • The study demonstrates the feasibility of developing entirely synthetic carbohydrate-based anticancer vaccines.
  • Further research into optimized vaccine design is warranted for effective cancer immunotherapy.

More Related Videos

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...